Life after SOLO-2: is olaparib really inducing platinum resistance in BRCA-mutated (BRCAm), PARP inhibitor (PARPi)-resistant, recurrent ovarian cancer?

Ann Oncol. 2022 Aug 12;S0923-7534(22)03867-4. doi: 10.1016/j.annonc.2022.08.003. Online ahead of print.
No abstract available

Publication types

  • Editorial